Screening For BCRL In Targeted Therapy For Breast Cancer
Recruiting
Observational Study
LymphedemaLymphedema ArmLymphedema of Upper ArmLymphedema of Upper LimbLymphedema of the HandsEdemaEdema ArmBreast Cancer LymphedemaBreast Cancer MetastaticBreast Cancer StageBreast Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 – 80
Sex
Female
Study type
Observational
Participants needed
261 (estimated)
Sponsor
Massachusetts General Hospital · Other
Who this trial is looking for
This trial is looking for women who have had breast cancer and are receiving targeted therapy. Participants will help track swelling related to their treatment.
Are You a Good Fit for This Trial?
You may be able to join if
I am a female between 18 and 80 years old
I have a history of breast cancer
I am at least 4 weeks post-surgery
I am receiving targeted therapy for early or metastatic breast cancer
I may or may not have edema
You may not be able to join if
I cannot raise my arm to at least 90 degrees
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
This a prospective, longitudinal study designed to track edema and Breast Cancer Related Lymphedema (BCRL) onset in breast cancer patients taking targeted therapy treatments for early and metastatic breast cancer.
A Perometer and Sozo devise will be used to measure volume changes
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Subjects who are receiving treatment in the MGH Breast Cancer Center who are enrolled in a DF/HCC-regulated targeted therapy trial for the treatment of early or metastatic breast cancer or patients being treated with a targeted therapy that may alter their risk of developing e…
Inclusion Criteria:
* Subjects who are receiving treatment in the MGH Breast Cancer Center who are enrolled in a DF/HCC-regulated targeted therapy trial for the treatment of early or metastatic breast cancer or patients being treated with a targeted therapy that may alter their risk of developing edema or BCRL will be eligible.
* Subjects that will be eligible for the study include:
* Females between 18 and 80 years of age
* With a history of breast cancer
* 4 weeks or more post-surgery
* With or without edema
* Undergoing treatment with targeted therapy for early or metastatic disease.
Exclusion Criteria:
\- Patients who cannot attain 90 degrees of shoulder abduction (position of measurement with Perometer).
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.
